Metabotropic signaling downstream of GABAA receptors suppresses neuroinflammation in Parkinson’s disease

Wenjing Lu, Lirong Zhang, Xi Chen, Xiaoxi Ren, Fenqin Xue, Feilong Zhang, Jing Sun, Wei Wang, Haixia Huang, Jianliang Zhang · 2026

Read Metabotropic signaling downstream of GABAA receptors suppresses neuroinflammation in Parkinson’s disease by Wenjing Lu, Lirong Zhang, Xi Chen, Xiaoxi Ren, Fenqin Xue, Feilong Zhang, Jing Sun, Wei Wang, Haixia Huang, Jianliang Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13578346.txt.

Description

Wenjing Lu and colleagues found a calming route in Parkinson's disease: a classic brake receptor that also sends slow chemical signals. Ongoing brain swelling, driven by immune cells called microglia, worsens Parkinson's, so taming it could slow disease. Their 2026 study tested GABA-A receptors, best known for fast braking, in a toxin-induced Parkinson's model in cells and mice.

Switching on those receptors strongly curbed swelling and the nerve damage that follows. The effect ran through a slow cascade: the receptor bound phospholipase C, released calcium from cell stores, and set phosphatases loose that blocked a key swelling switch. The authors propose GABA-A signalling as a fresh drug target against brain swelling in Parkinson's and related illnesses.

Catalog record

CREATORWenjing Lu, Lirong Zhang, Xi Chen, Xiaoxi Ren, Fenqin Xue, Feilong Zhang, Jing Sun, Wei Wang, Haixia Huang, Jianliang Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13578346

Browse the full library · About the Tower of Babel